Wei Ou

2.1k total citations
64 papers, 1.3k citations indexed

About

Wei Ou is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Wei Ou has authored 64 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Pulmonary and Respiratory Medicine, 26 papers in Oncology and 12 papers in Molecular Biology. Recurrent topics in Wei Ou's work include Lung Cancer Treatments and Mutations (25 papers), Lung Cancer Diagnosis and Treatment (19 papers) and Lung Cancer Research Studies (15 papers). Wei Ou is often cited by papers focused on Lung Cancer Treatments and Mutations (25 papers), Lung Cancer Diagnosis and Treatment (19 papers) and Lung Cancer Research Studies (15 papers). Wei Ou collaborates with scholars based in China, Pakistan and United States. Wei Ou's co-authors include Siyu Wang, Yi‐Long Wu, Xue-Ning Yang, Changjin Xu, Yicheng Pang, Zixin Liu, Ning Li, Ye Xiong, Hua Yang and Qin Fang and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Wei Ou

62 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wei Ou China 23 700 437 188 152 128 64 1.3k
Qamar J. Khan United States 23 380 0.5× 810 1.9× 392 2.1× 301 2.0× 171 1.3× 93 1.7k
Jan Poleszczuk Poland 22 268 0.4× 482 1.1× 235 1.3× 332 2.2× 422 3.3× 84 1.3k
Andrzej Świerniak Poland 22 164 0.2× 322 0.7× 253 1.3× 662 4.4× 647 5.1× 114 1.6k
Leili Shahriyari United States 16 138 0.2× 245 0.6× 134 0.7× 213 1.4× 176 1.4× 33 811
Jana Lipková United States 14 118 0.2× 136 0.3× 160 0.9× 223 1.5× 75 0.6× 30 1.4k
Qing Cheng China 14 70 0.1× 280 0.6× 125 0.7× 230 1.5× 23 0.2× 46 760
Benjamin Ribba France 20 159 0.2× 443 1.0× 274 1.5× 505 3.3× 635 5.0× 59 1.5k
Christian Bayer Germany 19 211 0.3× 380 0.9× 553 2.9× 303 2.0× 12 0.1× 72 1.5k
Vinay Varadan United States 24 262 0.4× 457 1.0× 398 2.1× 731 4.8× 9 0.1× 69 1.8k
Martin Peifer Germany 22 709 1.0× 894 2.0× 439 2.3× 1.0k 6.8× 5 0.0× 54 2.2k

Countries citing papers authored by Wei Ou

Since Specialization
Citations

This map shows the geographic impact of Wei Ou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei Ou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei Ou more than expected).

Fields of papers citing papers by Wei Ou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wei Ou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei Ou. The network helps show where Wei Ou may publish in the future.

Co-authorship network of co-authors of Wei Ou

This figure shows the co-authorship network connecting the top 25 collaborators of Wei Ou. A scholar is included among the top collaborators of Wei Ou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wei Ou. Wei Ou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tang, Jinming, Min Su, Yuhang Xiao, et al.. (2025). The role of LncRNA SNHG3 in human cancers. Discover Oncology. 16(1). 1812–1812.
2.
Ou, Wei, Xi Li, Lin Ding, et al.. (2025). GLA deficiency causes cardiac hypertrophy via enhanced autophagy. Science China Life Sciences. 68(6). 1689–1702. 1 indexed citations
3.
Xu, Changjin, Wei Ou, Yicheng Pang, et al.. (2024). Theoretical exploration and controller design of bifurcation in a plankton population dynamical system accompanying delay. Discrete and Continuous Dynamical Systems - S. 18(5). 1182–1211. 22 indexed citations
4.
Xu, Changjin, Wei Ou, Yicheng Pang, et al.. (2023). Hopf Bifurcation Control of a Fractional-Order Delayed Turbidostat Model via a Novel Extended Hybrid Controller. match Communications in Mathematical and in Computer Chemistry. 91(2). 367–413. 26 indexed citations
5.
Ou, Wei, Changjin Xu, Zixin Liu, et al.. (2023). Mathematical study on bifurcation dynamics and control mechanism of tri‐neuron bidirectional associative memory neural networks including delay. Mathematical Methods in the Applied Sciences. 48(7). 7820–7844. 58 indexed citations
6.
7.
Ou, Wei, et al.. (2023). Synthesis of poly (propylene carbonate) diol-based waterborne polyurethane modified by epoxy resin with anticorrosion properties. Journal of Coatings Technology and Research. 21(1). 319–328. 5 indexed citations
9.
Yang, Weixiong, Na You, Minghan Jia, et al.. (2020). Undetectable circulating tumor DNA levels correlate with low risk of recurrence/metastasis in postoperative pathologic stage I lung adenocarcinoma patients. Lung Cancer. 146. 327–334. 15 indexed citations
10.
Xiao, Yuhang, Ta Xiao, Wei Ou, et al.. (2020). LncRNA SNHG16 as a potential biomarker and therapeutic target in human cancers. Biomarker Research. 8(1). 41–41. 33 indexed citations
11.
Xiao, Yuhang, Min Su, Wei Ou, et al.. (2019). Involvement of noncoding RNAs in epigenetic modifications of esophageal cancer. Biomedicine & Pharmacotherapy. 117. 109192–109192. 17 indexed citations
12.
Ou, Wei, et al.. (2017). Impacts of EGFR mutation and EGFR-TKIs on incidence of brain metastases in advanced non-squamous NSCLC. Clinical Neurology and Neurosurgery. 160. 96–100. 30 indexed citations
13.
Li, Ning, Miao Xu, Mu-Yan Cai, et al.. (2015). Elevated serum bilirubin levels are associated with improved survival in patients with curatively resected non-small-cell lung cancer. Cancer Epidemiology. 39(5). 763–768. 29 indexed citations
14.
Ou, Wei, Yin Li, Qin Fang, et al.. (2013). Epidermal Growth Factor Receptor Mutation Status and Adjuvant Chemotherapy in Resected Advanced Non–Small-Cell Lung Cancer. Clinical Lung Cancer. 14(4). 376–382. 15 indexed citations
16.
Zheng, Yan, Wei Ou, Qin Fang, et al.. (2011). Association Between Hormone Receptor Expression and Epidermal Growth Factor Receptor Mutation in Patients Operated on for Non-Small Cell Lung Cancer. The Annals of Thoracic Surgery. 91(5). 1562–1567. 27 indexed citations
17.
Ou, Wei, Ye Xiong, Bin-Bin Zhang, et al.. (2010). Adjuvant Carboplatin-based Chemotherapy in Resected Stage IIIA-N2 Non-small Cell Lung Cancer. Journal of Thoracic Oncology. 5(7). 1033–1041. 17 indexed citations
19.
Wang, Siyu, et al.. (2008). Risk of cerebral metastases for postoperative locally advanced non-small-cell lung cancer. Lung Cancer. 64(2). 238–243. 50 indexed citations
20.
Wu, Yi‐Long, et al.. (2002). A randomized trial of systematic nodal dissection in resectable non-small cell lung cancer. Lung Cancer. 36(1). 1–6. 234 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026